{"id":"https://openalex.org/W4389219476","doi":"https://doi.org/10.1182/blood-2023-190613","title":"CYT-338 NK Cell Engager Mutispecific Antibody Engagement of NKp46 Activation Receptor Overcomes Anti-CD38 Mab Mediated Fratricide of NK Cells and Accords Enhanced Cancer Immunotherapy","display_name":"CYT-338 NK Cell Engager Mutispecific Antibody Engagement of NKp46 Activation Receptor Overcomes Anti-CD38 Mab Mediated Fratricide of NK Cells and Accords Enhanced Cancer Immunotherapy","publication_year":2023,"publication_date":"2023-11-02","ids":{"openalex":"https://openalex.org/W4389219476","doi":"https://doi.org/10.1182/blood-2023-190613"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2023-190613","doi":"https://doi.org/10.1182/blood-2023-190613","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2023-190613","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070646799","display_name":"Vishal Khairnar","orcid":"https://orcid.org/0000-0002-3584-7530","observed_orcids":["https://orcid.org/0000-0002-3584-7530"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vishal Khairnar","raw_affiliation_strings":["1Cytovia Therapeutics, NATICK, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cytovia Therapeutics, NATICK, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084199910","display_name":"Liang Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liang Lin","raw_affiliation_strings":["1Cytovia Therapeutics, NATICK, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cytovia Therapeutics, NATICK, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086598447","display_name":"Hao-Ming Chang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hao-Ming Chang","raw_affiliation_strings":["1Cytovia Therapeutics, NATICK, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cytovia Therapeutics, NATICK, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108548704","display_name":"Sourindra N. Maiti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sourindra Maiti","raw_affiliation_strings":["2Cytovia Therapeutics, Inc, NATICK, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cytovia Therapeutics, Inc, NATICK, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101273711","display_name":"Solgalim Diaz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Solgalim Diaz","raw_affiliation_strings":["1Cytovia Therapeutics, NATICK, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cytovia Therapeutics, NATICK, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035583924","display_name":"Ofer Mandelboim","orcid":"https://orcid.org/0000-0002-9354-1855","observed_orcids":["https://orcid.org/0000-0002-9354-1855"]},"institutions":[{"id":"https://openalex.org/I197251160","display_name":"Hebrew University of Jerusalem","ror":"https://ror.org/03qxff017","country_code":"IL","type":"education","lineage":["https://openalex.org/I197251160"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ofer Mandelboim","raw_affiliation_strings":["3Hebrew University Of Jerusalem, Jerusalem, ISR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hebrew University Of Jerusalem, Jerusalem, ISR","institution_ids":["https://openalex.org/I197251160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090028348","display_name":"Tariq I. Mughal","orcid":"https://orcid.org/0000-0003-1005-7724","observed_orcids":["https://orcid.org/0000-0003-1005-7724"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tariq Mughal","raw_affiliation_strings":["4Department of Hematology/Oncology, City of Hope, Duarte, CA","5University of Colorado, Golden, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Hematology/Oncology, City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]},{"raw_affiliation_string":"5University of Colorado, Golden, CO","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029371474","display_name":"Dan A. Chiche","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dan Chiche","raw_affiliation_strings":["2Cytovia Therapeutics, Inc, NATICK, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cytovia Therapeutics, Inc, NATICK, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039576650","display_name":"Elisabetta Burchi","orcid":"https://orcid.org/0000-0002-7596-0212","observed_orcids":["https://orcid.org/0000-0002-7596-0212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisabetta Burchi","raw_affiliation_strings":["6Cytovia Therapeutics, Adventura, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Cytovia Therapeutics, Adventura, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040446667","display_name":"Armand Bensussan","orcid":"https://orcid.org/0000-0002-0409-2497","observed_orcids":["https://orcid.org/0000-0002-0409-2497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Armand Bensussan","raw_affiliation_strings":["7Faculte De Medecine De Creteil, Creteil, FRA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Faculte De Medecine De Creteil, Creteil, FRA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037470160","display_name":"Jean Kadouche","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean Kadouche","raw_affiliation_strings":["1Cytovia Therapeutics, NATICK, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cytovia Therapeutics, NATICK, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082004555","display_name":"Ola Landgren","orcid":"https://orcid.org/0000-0001-6485-4839","observed_orcids":["https://orcid.org/0000-0001-6485-4839"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I4210157065","display_name":"Sylvester Comprehensive Cancer Center","ror":"https://ror.org/0552r4b12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ola Landgren","raw_affiliation_strings":["8Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL","9Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]},{"raw_affiliation_string":"9Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048966043","display_name":"Dickran Gano Kazandjian","orcid":"https://orcid.org/0000-0002-6593-0917","observed_orcids":["https://orcid.org/0000-0002-6593-0917"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I4210157065","display_name":"Sylvester Comprehensive Cancer Center","ror":"https://ror.org/0552r4b12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dickran Kazandjian","raw_affiliation_strings":["10Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami","11Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami","12Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD","13Center for Cancer Research, Lymphoid Malignancies Branch, Multiple Myeloma Program, NIH, Potomac, MD","14Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL","15U.S. Food & Drug Administration, Silver Spring, MD","16Sylvester Comprehensive Cancer Center, Miami, FL","17Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL","18Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL","19University of Miami, Coral Gables, FL","20Center for Cancer Research, Lymphoid Malignancies Branch, Multiple Myeloma Program, National Institutes of Health, Miami, FL","10Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami; 11Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami; 12Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD; 13Center for Cancer Research, Lymphoid Malignancies Branch, Multiple Myeloma Program, NIH, Potomac, MD; 14Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; 15U.S. Food & Drug Administration, Silver Spring, MD; 16Sylvester Comprehensive Cancer Center, Miami, FL; 17Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; 18Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; 19University of Miami, Coral Gables, FL; 20Center for Cancer Research, Lymphoid Malignancies Branch, Multiple Myeloma Program, National Institutes of Health, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]},{"raw_affiliation_string":"11Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]},{"raw_affiliation_string":"12Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"raw_affiliation_string":"13Center for Cancer Research, Lymphoid Malignancies Branch, Multiple Myeloma Program, NIH, Potomac, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"14Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]},{"raw_affiliation_string":"15U.S. Food & Drug Administration, Silver Spring, MD","institution_ids":["https://openalex.org/I1320320070"]},{"raw_affiliation_string":"16Sylvester Comprehensive Cancer Center, Miami, FL","institution_ids":["https://openalex.org/I4210157065"]},{"raw_affiliation_string":"17Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]},{"raw_affiliation_string":"18Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]},{"raw_affiliation_string":"19University of Miami, Coral Gables, FL","institution_ids":["https://openalex.org/I145608581"]},{"raw_affiliation_string":"20Center for Cancer Research, Lymphoid Malignancies Branch, Multiple Myeloma Program, National Institutes of Health, Miami, FL","institution_ids":["https://openalex.org/I1299303238"]},{"raw_affiliation_string":"10Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami; 11Myeloma Division, University of Miami, Sylvester Comprehensive Cancer Center, Miami; 12Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD; 13Center for Cancer Research, Lymphoid Malignancies Branch, Multiple Myeloma Program, NIH, Potomac, MD; 14Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; 15U.S. Food & Drug Administration, Silver Spring, MD; 16Sylvester Comprehensive Cancer Center, Miami, FL; 17Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; 18Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; 19University of Miami, Coral Gables, FL; 20Center for Cancer Research, Lymphoid Malignancies Branch, Multiple Myeloma Program, National Institutes of Health, Miami, FL","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1320320070","https://openalex.org/I145608581","https://openalex.org/I4210157065"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039647208","display_name":"Armin V. Rath","orcid":"https://orcid.org/0009-0006-6960-5376","observed_orcids":["https://orcid.org/0009-0006-6960-5376"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Armin Rath","raw_affiliation_strings":["21Cytovia Therapeutics, Aventura, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"21Cytovia Therapeutics, Aventura, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004196416","display_name":"Daniel Teper","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Teper","raw_affiliation_strings":["22Cytovia Therapeutics, NATICK, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"22Cytovia Therapeutics, NATICK, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100317951","display_name":"Wei Li","orcid":"https://orcid.org/0000-0001-5069-5945","observed_orcids":["https://orcid.org/0000-0001-5069-5945"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["1Cytovia Therapeutics, NATICK, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cytovia Therapeutics, NATICK, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021375981","display_name":"Antonio Arulanandam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio Arulanandam","raw_affiliation_strings":["1Cytovia Therapeutics, NATICK, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cytovia Therapeutics, NATICK, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"142","issue":"Supplement 1","first_page":"6725","last_page":"6725"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.01940000057220459,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nkp46","display_name":"NKp46","score":0.9169999957084656},{"id":"https://openalex.org/keywords/cd16","display_name":"CD16","score":0.7940000295639038},{"id":"https://openalex.org/keywords/anti-cd38-monoclonal-antibody","display_name":"anti-CD38 monoclonal antibody","score":0.8840000033378601},{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.984000027179718},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.7519999742507935},{"id":"https://openalex.org/keywords/nk-cell-redirection","display_name":"NK cell redirection","score":0.7229999899864197},{"id":"https://openalex.org/keywords/nk-cell-exhaustion","display_name":"NK cell exhaustion","score":0.8840000033378601},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-phagocytosis","display_name":"antibody-dependent cellular phagocytosis","score":0.7670000195503235},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.5070000290870667},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6679999828338623},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.7665208578109741},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5400221347808838},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5221477150917053},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4725237488746643},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4660991430282593},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4148731529712677},{"id":"https://openalex.org/C2781462264","wikidata":"https://www.wikidata.org/wiki/Q78482053","display_name":"CD16","level":5,"score":0.41423875093460083},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37689924240112305},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34570473432540894},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3425096869468689},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.2861369252204895},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.1239226758480072}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2023-190613","doi":"https://doi.org/10.1182/blood-2023-190613","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2023-190613","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7400000095367432,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310163581","https://openalex.org/W4283382628","https://openalex.org/W2989253463","https://openalex.org/W4282968809","https://openalex.org/W2903132419","https://openalex.org/W4282982052","https://openalex.org/W3039959250","https://openalex.org/W4389235403","https://openalex.org/W2988236032","https://openalex.org/W3176072338"],"abstract_inverted_index":{"Background":[0],"and":[1,46,80,100,102,141,249,255,260,304,405,443],"Significance:":[2],"Despite":[3],"the":[4,8,17,50,187,234,270,283,298,317,324,344,352,363,412,436,470],"clinical":[5],"success":[6],"of":[7,19,76,116,144,147,173,203,238,272,279,334,387,417,438],"first":[9],"anti-CD38":[10,199,223,326,426],"targeted":[11],"monoclonal":[12],"antibody,":[13],"daratumumab,":[14,225],"approved":[15,453],"for":[16,73,167,189,243,400,454],"treatment":[18,41],"multiple":[20],"myeloma":[21],"(MM),":[22],"significant":[23],"challenges":[24],"remain":[25],"such":[26],"as":[27],"CD38":[28,96,318],"antigen":[29],"loss/internalization":[30],"and/or":[31],"natural":[32],"killer":[33],"(NK)":[34],"cell":[35,90,113,181,373,403,408,419],"fratricide":[36,182,202,263,278,320,345,353,374,380,404],"resulting":[37],"in":[38,233,440,467,469],"resistance":[39],"to":[40,109,136,184,275,296,315,337,369,431],"over":[42,150,165],"time.":[43,151],"Study":[44],"Design":[45],"Methods:":[47],"To":[48,211],"overcome":[49,198,316],"above-mentioned":[51],"challenges,":[52],"Cytovia":[53],"has":[54,161],"utilized":[55],"its":[56,137],"proprietary":[57],"multifunctional":[58],"tetravalent":[59],"Flex":[60],"Engager":[61],"TM":[62],"bispecific":[63],"antibody":[64,93,168,342],"IgG":[65],"scaffold":[66],"platform":[67],"that":[68,94,159,195,332,351,378],"contains":[69],"a":[70,162],"flexible":[71],"linker":[72],"simultaneous":[74],"engagement":[75,386],"effector":[77],"immune":[78],"cells":[79,108,119,135,149,205,219,281,312],"tumors":[81,99],"targets.":[82],"Through":[83,288],"this,":[84],"we":[85,154,214,292,329],"generated":[86],"CYT-338,":[87,349],"an":[88,423],"NK":[89,107,112,134,148,180,204,218,262,280,311,372,402,407,418],"engager":[91],"mutispecific":[92],"targets":[95],"on":[97,106,310],"MM":[98,117,129,174,429,465],"NKp46":[101,208,303,338,358,388,394],"CD16":[103,305],"activation":[104,139,209,359,389,395],"receptors":[105],"mediate":[110],"potent":[111],"redirected":[114],"killing":[115,126,145],"tumor":[118],"more":[120],"efficaciously":[121],"than":[122],"daratumumab.":[123,432],"In":[124,152,361],"serial":[125],"assays":[127],"against":[128,428],"tumors,":[130],"CYT-338":[131,160,196,226,309,335,399,439],"reversed":[132,343,384],"dysfunctional":[133],"original":[138],"state":[140],"prevented":[142],"exhaustion":[143],"activity":[146],"addition,":[153,362],"have":[155,293,330],"also":[156,268,382],"previously":[157],"reported":[158],"higher":[163],"potency":[164,414],"daratumumab":[166,185],"dependent":[169],"cellular":[170],"phagocytosis":[171],"(ADCP)":[172],"tumors.":[175],"Preclinically,CYT-338":[176],"shows":[177],"significantly":[178],"reduced":[179],"compared":[183,430],"but":[186],"reason":[188],"this":[190,212],"was":[191,355,367],"unknown.":[192],"We":[193,267],"hypothesized":[194],"could":[197],"mAb":[200,241,274,366],"mediated":[201,356],"by":[206,264,308,323,339,348,357,385,398],"engaging":[207],"receptor.":[210,390],"end":[213],"incubated":[215],"peripheral":[216],"blood":[217],"(PBNK)":[220],"with":[221,251,411,445,463],"either":[222,232],"mAb,":[224],"or":[227,236,452],"human":[228],"IgG1":[229,341],"isotype":[230],"control":[231],"presence":[235],"absence":[237],"blocking":[239],"anti-NKp46":[240,273,340,365],"(IgG1)":[242],"24":[244],"hrs":[245],"at":[246],"37":[247],"oC":[248],"stained":[250],"Annexin":[252],"V":[253],"apoptosis":[254],"Zombie":[256],"NIR":[257],"viability":[258],"dye":[259],"analyzed":[261],"flow":[265],"cytometry.":[266],"evaluated":[269],"ability":[271],"inhibit":[276,370],"daratumumab-mediated":[277,371],"under":[282],"same":[284],"conditions.":[285],"Current":[286],"Status:":[287],"functional":[289],"preclinical":[290],"investigations,":[291],"been":[294],"able":[295,314,368],"deconvolute":[297],"novel":[299],"molecular":[300],"mechanisms":[301],"whereby":[302],"co-engagement":[306],"signals":[307,321],"are":[313],"apoptotic":[319],"induced":[322],"single":[325,364],"mAb.":[327],"Specifically,":[328],"found":[331],"blockade":[333],"binding":[336],"protection":[346,354],"provided":[347,397],"indicating":[350],"signals.":[360],"providing":[375],"direct":[376],"evidence":[377],"daratumumabmediated":[379],"can":[381],"be":[383],"Conclusions:":[391],"The":[392],"unique":[393],"mechanism":[396],"reducing":[401],"maintaining":[406],"levels":[409],"together":[410],"enhanced":[413],"including":[415],"reversal":[416],"dysfunction":[420],"makes":[421],"it":[422],"attractive":[424],"best-in-class":[425],"therapeutic":[427],"These":[433],"results":[434],"support":[435],"development":[437,468],"both":[441],"monotherapy":[442],"combination":[444],"other":[446],"complementary":[447],"immunotherapy":[448],"agents":[449],"being":[450],"developed":[451],"MM.":[455],"A":[456],"first-in-human":[457],"Phase":[458],"1":[459],"study":[460],"targeting":[461],"patients":[462],"relapsed/refractory":[464],"is":[466],"U.S.":[471]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-12-02T00:00:00"}